Cryoglobulinemia related to hepatitis C virus infection

Digestive Diseases and Sciences

Volumn 52, Issue 4, 2007, Pages 897-907

  Dore, Maria Pina ^a   Fattovich, Giovanna ^b   Sepulveda, Antonia R ^d   Realdi, Giuseppe ^c  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Autoimmune disorders; Extrahepatic manifestations; Mixed cryoglobulinemia

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HLA DR3 ANTIGEN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MACROGOL; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RHEUMATOID FACTOR; RIBAVIRIN; RITUXIMAB; VIRUS RNA;

ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CRYOGLOBULINEMIA; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; KIDNEY TRANSPLANTATION; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; MONOTHERAPY; NEUROPATHY; NONHUMAN; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SURVIVAL RATE; THYROIDITIS; TREATMENT INDICATION; VASCULITIS; VIRUS HEPATITIS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; HEPATITIS C, CHRONIC; HUMANS;

EID: 33947574258     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9510-9     Document Type: Review

References (94)

1. Lorber B (1996) Are all diseases infectious? Ann Intern Med 125:844-851
2. Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J, Anaya JM, Font J, HISPAMEC Study Group (2005) Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257:549-557
3. El-Serag HB, Hampel H, Yeh C, Rabeneck L (2002) Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36:1439-1445
4. Gumber SC, Chopra S (1995) Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123:615-620
5. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas H, Njapoum C, Casarin C, Bonetti P, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G (1997) Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112:463-472
6. Major ME, Feinstone SM (1997) The molecular virology of hepatitis C. Hepatology 25:1527-1538
7. Pawlotsky JM, Lonjon I, Hezode C, Raynard B, Darthuy F, Remire J, Remire J, Soussy CJ, Dhumeaux D (1998) What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 27:1700-1702
8. Martinot-Peignoux M, Boyer N, Le Breton V, Le Guludec G, Castelnau C, Akremi R, Marcellin P (2000) A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C. Hepatology 31:726-729
9. Zignego AL, De Carli M, Monti M, Careccia G, La Villa G, Giannini C, D'Elios MM, Del Prete G, Gentilini P (1995) Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 47:58-64
10. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M, Alter HJ, Purcell RH (1990) Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transfection with Epstein-Barr virus. Proc Natl Acad Sci USA 87:6441-6444
11. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH (1992) Lack of protection against reinfectionwith hepatitis C virus. Science 258:135-140
12. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F (1995) Localization of hepatitis C virus antigens in liver and skin tissue of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 21:305-312
13. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F (1997) Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25:1237-1244
14. Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227-236
15. Sansonno D, Lauletta G, Nisi L, Gatti P, Pesola F, Pansini N, Dammacco F (2003) Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol 133:275-282
16. Daghestani L, Pomeroy C (1999) Renal manifestations of hepatitis C infection. Am J Med 106:347-354
17. Sim RB, Moestrup SK, Stuart GR, Lynch NJ, Lu J, Schwaeble WJ, Malhotra R (1998) Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin. Immunobiology 199:208-224
18. Ghebrehiwet B, Peerschke EI (1998) Structure and function of gC1q-R: a multiligand binding cellular protein. Immunobiology 199:225-238
19. Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B (2002) Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol 168:2441-2448
20. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282:938-941
21. Ichiki Y, He XS, Shimoda S, Ishibashi H, Keeffe EB, Rossaro L, Gershwin ME (2005) T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun Rev 4:82-95
22. Freni MA, Artuso D, Gerken G, Spanti C, Marafioti T, Alessi N, Spadaro A, Ajello A, Ferrau O (1995) Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relations to markers of autoimmunity. Hepatology 22:389-394
23. Mosnier JF, Degott C, Marcellin P, Henin D, Erlinger S, Benhamou JP (1993) The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 17:366-371
24. Racanelli V, Sansonno D, Piccoli C, D'Amore FP, Tucci FA, Dammacco F (2001) Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 167:21-29
25. Bertoletti A, DíElios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G, Ferrari C (1997) Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193-199
26. Manns MP, Rambusch EG (1999) Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 31(Suppl 1):39-42
27. Lenzi M, Johson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R (1991) Antibodies to hepatitis C virus in auto-immune liver disease: evidence for geographical heterogeneity. Lancet 338:277-280
28. Bianchi FB (1993) Auto-immune hepatitis: the lesson of the discovery of hepatitis C virus. J Hepatol 18:273-275
29. Zauli D, Ghetti S, Grassi A, Descovich C, Cassani F, Ballardini G, Muratori L, Bianchi FB (1997) Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25:1105-1107
30. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P, Beaugrand M (1992) Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323
31. Divano MC, Parodi A, Rebora A (1992) Lichen planus, liver kidney microsomal (LKM-1) antibodies and hepatitis C virus antibodies. Dermatology 185:132-133
32. Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF (1999) Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol (Oxf) 50:503-509
33. Custro N, Montalto G, Scafidi V, Soresi M, Gallo S, Tripi S, Notarbartolo A (1997) Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. J Endocrinol Invest 25:938-946
34. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470
35. Cacoub P, Lunel-Fabiani F, Du LT (1992) Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 7:605-606
36. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP (1999) Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328-333
37. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, O'Rahilly S, Shore S, Tom BD, Alexander GJ (1999) Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30:1059-1063
38. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592-599
39. Pawlotsky JM, Bouvier M, Fromont P, Deforges L, Duval J, Dhumeaux D, Bierling P (1995) Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 23:635-639
40. Eddy S, Wim R, Peter VE, Tanja R, Jan T, Werner VS (1999) Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection. Dig Dis Sci 44:186-189
41. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G (2003) HCV infection and extrahepatic manifestations. Hepatogastroenterology 50:1149-1154
42. Lunel F (1994) Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology 107:1550-1554
43. Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, Bianchi FB (1995) Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 37:406-412
44. Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde KH, Decker R, Manns MP (1992) Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339:267-269
45. Koskinas J, McFarlane BM, Nouri-Aria KT, Tibbs CJ, Mizokami M, Donaldson PT, McFarlane IG, Williams R (1994) Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 107:1436-1442
46. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB (1995) Signifi-cance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. Dig Dis Sci 40:2098-2106
47. Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54-63
48. Brouet JC, Clouvel JP, Darun F, Klein M, Seligmann M (1974) Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 57:775-788
49. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287-308
50. D'Amico G, Colasanti G, Ferrario F, Sinico RA (1989) Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35:1004-1014
51. Realdi G, Alberti A, Rigoli A, Tremolada F (1974) Immune complexes and Australia antigen in cryoglobulinemic sera. Z Immun Forsch 147:114-126
52. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC (1977) Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296:1501-1504
53. Pascual M, Perrin L, Giostra E, Schifferli JA (1990) Hepatitis C virus in patients with cryoglobulinemia type II [Letter]. J Infect Dis 162:569-570
54. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M (1994) Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 84:3047-3053
55. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G, Zanetti A (1992) Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573-577
56. Monteverde A (1996) Le crioglobulinemie miste. In Atti del 97? Congresso della Società Italiana di Medicina Interna. L. Pozzi (ed), pp 3-152
57. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300
58. Agnello V (1997) The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 19:111-129
59. Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection and type II cryoglobulinemia. N Engl J Med 327:1490-1495
60. Perl A, Wang N, Williams JM, Hunt MJ, Rosenfeld SI, Condemi JJ, Packman CH, Abraham GN (1987) Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemia. J Immunol 139:3512-3520
61. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L (2002) Cryoglobulinemia vasculitis. Curr Opin Rheumatol 14:29-35
62. Dammacco F, Sansonno D (1997) Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 15:97-119
63. Abel G, Zhang QX, Agnello V (1993) Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 36:1341-1349
64. Willson RA (1997) Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92:4-17
65. De Vita S, De Re V, Sansonno D, Sorrentino D, Corte RL, Pivetta B, Gasparotto D, Racanelli V, Marzotto A, Labombarda A, Gloghini A, Ferraccioli G, Monteverde A, Carbone A, Dammacco F, Boiocchi M (2000) Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology 31:182-189
66. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G (1996) Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 94:544-550
67. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinemia - a clinical and laboratory study II. Cryoglobulins with rheumatoid factor activity. Am J Med 40:837-856
68. Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P, Morselli M, Emilia G, Torelli G (1996) Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 94:373-375
69. Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ (1999) Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 29:543-547
70. Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, Villa GL, Laffi G, Gentilini P (2000) T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 31:474-479
71. Kitay-Cohen Y, Amiel A, Hilzenrat N, Buskila D, Ashur Y, Fejgin M, Gaber E, Safadi R, Tur-Kaspa R, Lishner M (2000) Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96:2910-2912
72. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe JM (2001) The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97:1555-1559
73. Tarantino A, Campise M, Banfi G, Confalonieri R, Bucci A, Montoli A, Colasanti G, Damilano I, D'Amico G, Minetti L, Ponticelli C (1995) Long-term predictors of survival in essentialmixed cryoglobulinemic glomerulonephritis. Kidney Int 47:618-623
74. Tarantino A, Moroni G, Banfi G, Manzoni C, Segagni S, Ponticelli C (1994) Renal replacement therapy in cryoglobulinaemic nephritis. Nephrol Dial Transplant 9:1426-1430
75. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D (2000) Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27:2172-2178
76. Bonomo L, Casato M, Afeltra A, Caccavo D (1987) Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 83:726-730
77. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A(1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-756
78. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC (1994) Cryoglobulinemia in chronic liver diseases: role of HCV and liver damage. Gastroenterology 106:1291-300
79. Ferri C, Marzo E, Longomabardo G, Lombardini F, La Civita L, Vanacore R, Liberati AM, Gerli R, Greco F, Moretti A (1993) Interferon-alpha in mixed cryoglobulinemia patients: A randomized crossover-controlled trial. Blood 81:1132-1136
80. Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Iacobelli AR, Lauletta G, Rizzi R (1994) Natural interferon-alpha versus its combination with 6-methyl-prednisolone therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 84:3336-3343
81. Ferri C, Marzo E, Longomabardo G, Lombardini F, La Civita L, Vanacore R, Gentilini P, Bombardieri S, Zignego AL (1993) Interferon-alpha in mixed cryoglobulinemia patients: a randomized crossover-controlled trial. Blood 81:1132-1136
82. Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L (1991) Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 78:3142-3147
83. Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, Mazzilli C, Antonelli G, Bonomo L (1997) Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90:3865-3873
84. Cid MC, Hernandez-Rodriguez J, Robert J, del Rio A, Casademont J, Coll-Vinent B, Grau JM, Kleinman HK, Urbano-Marquez A, Cardellach F (1999) Interferon-alpha may exacerbate cryoglobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity. Arthritis Rheum 42:1051-1055
85. Suzuki H, Takei T, Tsuji H, Nishikawa T (2000) Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection. Intern Med 39:397-400
86. Zuckerman, E, Keren, D, Slobodin, G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D (2000) Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27:2172-2178
87. Alric L, Plaisier E, Thebault S, Peron JM, Rostaing L, Pourrat J, Ronco P, Piette JC, Cacoub P (2004) Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 43:617-623
88. Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro G, Maso LD, Carniello G, Virgolini L, Tirelli U, Pozzato G (2005) Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 42:632-638
89. Cacoub P, Saadoun D, Limal N, Sene D, Lidove O (2005) PEGy-lated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52:911-915
90. Levine JW, Gota C, Fessler BJ, Calabrese LH, Cooper SM (2005) Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 32:1164-1167
91. Kamar N, Rostaing L, Alric L (2006) Treatment of hepatitis C virus-related glomerulonephritis. Kidney Int 69:436-439
92. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101:3818-3826
93. Zaja F, De Vita S, Mazzaro C (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827-3834
94. Basse G, Ribes D, Kamar N, Mehrenberger M, Esposito L, Guitar J, Lavayssiere L, Oksman F, Dur D, Rostaing L (2005) Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation 15:1560-1564